| Product Code: ETC10185669 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Primary Immunodeficiency Disorders Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Primary Immunodeficiency Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 China Primary Immunodeficiency Disorders Market - Industry Life Cycle |
3.4 China Primary Immunodeficiency Disorders Market - Porter's Five Forces |
3.5 China Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Disorder Type, 2021 & 2031F |
3.6 China Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 China Primary Immunodeficiency Disorders Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 China Primary Immunodeficiency Disorders Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Primary Immunodeficiency Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of primary immunodeficiency disorders in China. |
4.2.2 Growth in healthcare infrastructure and facilities leading to better access to treatment. |
4.2.3 Rising prevalence of primary immunodeficiency disorders due to factors like pollution and lifestyle changes. |
4.3 Market Restraints |
4.3.1 Limited availability of advanced treatment options in China. |
4.3.2 High costs associated with the treatment of primary immunodeficiency disorders. |
4.3.3 Lack of skilled healthcare professionals specializing in managing primary immunodeficiency disorders. |
5 China Primary Immunodeficiency Disorders Market Trends |
6 China Primary Immunodeficiency Disorders Market, By Types |
6.1 China Primary Immunodeficiency Disorders Market, By Disorder Type |
6.1.1 Overview and Analysis |
6.1.2 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Disorder Type, 2021 - 2031F |
6.1.3 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Antibody Deficiency, 2021 - 2031F |
6.1.4 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Combined Immunodeficiency, 2021 - 2031F |
6.1.5 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Phagocytic Deficiency, 2021 - 2031F |
6.1.6 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Complement Deficiency, 2021 - 2031F |
6.2 China Primary Immunodeficiency Disorders Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Immunoglobulin Replacement, 2021 - 2031F |
6.2.3 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Bone Marrow Transplant, 2021 - 2031F |
6.2.4 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Enzyme Replacement, 2021 - 2031F |
6.2.5 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.3 China Primary Immunodeficiency Disorders Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Primary Immunodeficiency Disorders Market Revenues & Volume, By IVIG, 2021 - 2031F |
6.3.3 China Primary Immunodeficiency Disorders Market Revenues & Volume, By SCIG, 2021 - 2031F |
6.3.4 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.3.5 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Small Molecule Drugs, 2021 - 2031F |
6.4 China Primary Immunodeficiency Disorders Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.5 China Primary Immunodeficiency Disorders Market Revenues & Volume, By Homecare, 2021 - 2031F |
7 China Primary Immunodeficiency Disorders Market Import-Export Trade Statistics |
7.1 China Primary Immunodeficiency Disorders Market Export to Major Countries |
7.2 China Primary Immunodeficiency Disorders Market Imports from Major Countries |
8 China Primary Immunodeficiency Disorders Market Key Performance Indicators |
8.1 Average time to diagnosis for primary immunodeficiency disorders patients in China. |
8.2 Number of clinical trials and research studies focused on primary immunodeficiency disorders in China. |
8.3 Percentage of patients receiving appropriate and timely treatment for primary immunodeficiency disorders. |
9 China Primary Immunodeficiency Disorders Market - Opportunity Assessment |
9.1 China Primary Immunodeficiency Disorders Market Opportunity Assessment, By Disorder Type, 2021 & 2031F |
9.2 China Primary Immunodeficiency Disorders Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 China Primary Immunodeficiency Disorders Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 China Primary Immunodeficiency Disorders Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Primary Immunodeficiency Disorders Market - Competitive Landscape |
10.1 China Primary Immunodeficiency Disorders Market Revenue Share, By Companies, 2024 |
10.2 China Primary Immunodeficiency Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here